GoldenGolden
Auris Health

Auris Health

Auris Health (formerly Auris Surgical Robots) is a robotic medical company. Auris develops flexible robotics that allow for less invasive entry into the body through its natural openings. It is located in Redwood City, California and was founded in 2007.

Auris Health is a California-based company with a stated mission of creating a world where patient care is not pre-determined by medical tools that are limiting. It creates new tools for less invasive procedures for patients.

Product

The Monarch Platform is the first robotics platform cleared by the Federal Drug Administration and is designed for diagnostic and therapeutic bronchoscopic procedures. The platform is designed to be used by physicians to access small and hard-to-reach lung nodules for early diagnoses and targeted treatment of lung cancer. The endoscope itself is designed for greater reach and control and can be used via a controller interface, which the physician uses to navigate the periphery of the lungs. The platform can give 3D visuals of the patient's lungs so that physicians can have more access to the entirety of the organ.

The Monarch Platform has received several awards, including the Red Dot Award for best of the best product design, where the product was tested in various categories such a longevity and functionality.

Timeline

April 1, 2019
Johnson & Johnson announces that its Ethicon completed its $3.4 billion acquisition of Auris Health and the $2.8 billion divestiture of its Advanced Sterilization Products to Fortive.
February 13, 2019
Johnson & Johnson announced it was buying Auris Health

J&J said it would pay $3.4b in a cash deal and $2.35b more if Auris met predetermined milestones.

November 2018
Auris Health raises a $220,000,000 series E round from D1 Capital Partners, Lux Capital Management, Mithril Capital Management, Partner Fund Management, Senator Investment Group, Viking Global Investors and Wellington Management Group.
August 2017
Auris Health raises a $280,000,000 series D round from Coatue Management, Highland Capital Partners, Lux Capital Management and Mithril Capital Management.
August 9, 2016
Auris Health raises a $49,000,000 series C round.
September 23, 2015
Auris Health raises a $149,500,000 series B round from Lux Capital Management and Mithril Capital Management.
March 31, 2014
Auris Health raises a $34,400,000 series A round from Highland Capital Partners, Lux Capital Management and Mithril Capital Management.
June 2009
Auris Health raises a $125,000 venture round.
2007
Auris Health was founded by Christopher Velis.

Funding rounds

People

Name
Role
LinkedIn

DAN BRADFORD

VICE PRESIDENT OF OPERATIONS

DAVID M. STYKA

CHIEF FINANCIAL OFFICER

FRED MOLL, M.D.

FOUNDER AND CHIEF EXECUTIVE OFFICER

JOSH DEFONZO

CHIEF STRATEGY OFFICER

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
May 24, 2021
BioSpace
Noveome Biotherapeutics, Inc. Announces Christopher J. P. Velis as Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace
Encision Inc.
February 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray...
Conor Hale
January 22, 2021
FierceBiotech
Johnson & Johnson's DePuy Synthes division has received FDA clearance for its robotic-assisted orthopedic surgical platform for total knee replacements.
Fink Densford
April 2, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.